The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Open accessAbstract
p53 has a key role in the negative regulation of cell proliferation, in the maintenance of genomic stability, and in the suppression of transformation and tumorigenesis. To identify novel regulators of p53, we undertook two functional screens to isolate genes which bypassed either p53-mediated growth arrest or apoptosis. In both screens, we isolated cDNAs encoding macrophage migration inhibitory factor (MIF), a cytokine that was shown previously to exert both local and systemic proinflammatory activities. Treatment with MIF overcame p53 activity in three different biological assays, and suppressed its activity as a transcriptional activator. The observation that a proinflammatory cytokine, MIF, is capable of functionally inactivating a tumor suppressor, p53, may provide a link between inflammation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity33.”
From Inflammation and cancer (2002) · cites this paper as [33]
In the citing paper
“tetracycline regulated expression of wild-type p53 (GFP tagged) in the TGP53-4 mouse cell line (27) caused a significant decline in endogenous PGM activity (Fig. 5B).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,245
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“the tetracycline inducible system (22), and pBabe-puro-tet-GFP-”
Flagged first, then by citations
3 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Christen, 1999, Chronic infection and inflammation lead to cancer
Cited by
Sorted by citations
Items 301–400 of 649
Magalhães, E. S. D. S., Paiva, C. N., de Souza, H. S. P., Pyrrho, A. S., Mourão‐Sá, D., Figueiredo, R. T., Vieira‐de‐Abreu, A., Dutra, H. S., Silveira, M. S., Elsas, M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-124248 · Cited by 44
MIF loss impairs Myc-induced lymphomagenesis
Talos, F., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401653 · Cited by 41
Gesser, B., Rasmussen, M. K., Raaby, L., Rosada, C., Johansen, C., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2011) · Inflammation Research · doi:10.1007/s00011-011-0316-7 · Cited by 40
Guo, D., Guo, J. J., Yao, J., Jiang, K., Hu, J., Wang, B., Liu, H., Lin, L., Sun, W., & Jiang, X. (2016) · International Journal of Cancer · doi:10.1002/ijc.30278 · Cited by 41
Wang, X.-B., Tian, X. Y., Li, Y., Ли, Б., & Li, Z. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0640-3 · Cited by 40
Macrophage Migration Inhibitory Factor in Protozoan Infections
Bozza, M. T., Martins, Y. C., Carneiro, L. A. M., & Paiva, C. N. (2012) · Journal of Parasitology Research · doi:10.1155/2012/413052 · Cited by 39
Hassan, M. A., Hanrahan, J. P., Good, B., Mulcahy, G. M., & Sweeney, T. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-45 · Cited by 40
Welford, S. M., Dorie, M. J., Li, X., Haase, V. H., & Giaccia, A. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01618-09 · Cited by 40
Viganò, P., Cintorino, M., Schatz, F., Lockwood, C. J., & Arcuri, F. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0074-3 · Cited by 41
Zhou, Q., Yan, X., Gershan, J. A., Orentas, R. J., & Johnson, B. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1877 · Cited by 40
Larsen, M., Tazzyman, S. J., Lund, E. L., Junker, N., Lewis, C. E., Kristjansen, P. E. G., & Murdoch, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.012 · Cited by 40
Does resistance to apoptosis affect clinical response to antitumor drugs?
Borst, P., Borst, J. G., & Smets, L. A. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0187 · Cited by 40
Cai, T., Li, X., Ding, J., Luo, W., Li, J., & Huang, C. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795656001 · Cited by 39
de Souza, M. B., Curioni, O. A., Kanda, J. L., & de Carvalho, M. B. (2014) · Oncology Letters · doi:10.3892/ol.2014.2513 · Cited by 39
Krockenberger, M., Kranke, P., Häusler, S. F., Engel, J. B., Horn, E., Nürnberger, K., Wischhusen, J., Dietl, J., & Hönig, A. (2012) · PubMed · Cited by 39
Coumans, J. V. F., Gau, D. M., Poljak, A., Wasinger, V. C., Roy, P. S., & Moens, P. (2014) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2014.0075 · Cited by 39
Nasr, H. B., Chahed, K., Mestiri, S., Bouaouina, N., Snoussi, K., & Chouchane, L. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.06.006 · Cited by 39
Ohkawara, T., Nishihira, J., Takeda, H., Asaka, M., & Sugiyama, T. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-004-1526-3 · Cited by 39
Ko, S. C., Chapple, K. S., Hawcroft, G., Coletta, P. L., Markham, A. F., & Hull, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205869 · Cited by 39
Colon cancer in inflammatory bowel disease: recent trends, questions and answers
Viennot, S., Deleporte, A., Moussata, D., Nancey, S., Flourié, B., & Reimund, J. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(09)73154-9 · Cited by 38
Illescas, O., Gómez-Verján, J. C., García‐Velázquez, L., Govezensky, T., & Rodríguez‐Sosa, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00055 · Cited by 38
Yu, J., Ershler, M. A., Yu, L., Wei, M., Hackanson, B. W., Yokohama, A., Mitsui, T., Liu, C., Mao, H. C., Liu, S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205732 · Cited by 38
Sekiguchi, H., Washida, K., & Murakami, A. (2008) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2008054 · Cited by 38
Polyploidization and centrosome hyperamplification in inflammatory bronchi
Lothschütz, D., Jennewein, M., Pahl, S., Lausberg, H., Eichler, A., Mutschler, W., Hanselmann, R. G., & Oberringer, M. (2002) · Inflammation Research · doi:10.1007/pl00000323 · Cited by 39
Low-dose thalidomide in myeloma: Efficacy and biologic significance
Durie, B. G. M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70059-6 · Cited by 38
Lopes‐Coelho, F., Gouveia-Fernandes, S., & Serpa, J. (2018) · Tumor Biology · doi:10.1177/1010428318756203 · Cited by 39
Rasmussen, M. K., Iversen, L., Johansen, C., Finnemann, J., Olsen, L. S., Kragballe, K., & Gesser, B. (2008) · Inflammation Research · doi:10.1007/s00011-007-7220-1 · Cited by 37
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models
Fingerle‐Rowson, G., & Petrenko, O. (2007) · Cell Division · doi:10.1186/1747-1028-2-22 · Cited by 37
Xia, H. H., Lam, S., Huang, X., Wong, W., Leung, S., Yuen, S., Lan, H., & Yu, W. B. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/421915 · Cited by 37
Kleemann, R., Grell, M., Mischke, R., Zimmermann, G., & Bernhagen, J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753675785 · Cited by 37
Ioannou, K., Cheng, K. F., Crichlow, G. V., Birmpilis, A. I., Lolis, E., Tsitsilonis, O., & Al‐Abed, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2551 · Cited by 36
Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins
Kondo, N., Ishii, Y., Son, A., Sakakura-Nishiyama, J., Kwon, Y.-W., Tanito, M., Nishinaka, Y., Matsuo, Y., Nakayama, T., Taniguchi, M., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.030 · Cited by 36
UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53
Jiang, W., Ananthaswamy, H. N., Muller, H. K., Ouhtit, A., Bolshakov, S. V., Ullrich, S. E., El‐Naggar, A. K., & Kripke, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171066498 · Cited by 36
MIF contribution to progressive brain diseases
Matejuk, A., Benedek, G., Bucala, R., Matejuk, S., Offner, H., & Vandenbark, A. A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02993-6 · Cited by 40
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer
Alguel, H., & Rasch, S. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43457 · Cited by 37
CXCL12–CXCR4 Contributes to the Implication of Bone Marrow in Cancer Metastasis
Shi, J., Wei, Y., Xia, J., Wang, S., Wu, J., Chen, F., Huang, G., & Chen, J. (2014) · Future Oncology · doi:10.2217/fon.13.193 · Cited by 35
Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel
Pantouris, G., Khurana, L., Ma, A., Skeens, E., Reiss, K. M., Batista, V. S., Lisi, G. P., & Lolis, E. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.05.001 · Cited by 35
Sprong, T., Pickkers, P., Geurts-Moespot, A. J., van der Ven‐Jongekrijg, J., Neeleman, C., Knaup, M., Roy, D. L., Calandra, T., van der Meer, J. W. M., Sweep, F. C. G. J., et al. (2007) · Shock · doi:10.1097/01.shk.0000246898.65692.34 · Cited by 35
Kayser, K., Nwoye, J. O., Kosjerina, Z., Goldmann, T., Vollmer, E., Kaltner, H., André, S., & Gabius, H. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00289-7 · Cited by 35
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
Subbannayya, T., Leal, P., Barbhuiya, M. A., Raja, R., Renuse, S., Sathe, G. J., Pinto, S. M., Syed, N., Nanjappa, V., Patil, A. H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1855-z · Cited by 35
Wadgaonkar, R., Dudek, S. M., Zaiman, A., Linz-McGillem, L. A., Verin, A. D., Nurmukhambetova, S. T., Romer, L. H., & Garcia, J. G. N. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20472 · Cited by 35
Armstrong, M. E., Gantier, M. P., Li, L., Chung, W. Y., McCann, A. H., Baugh, J. A., & Donnelly, S. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7125 · Cited by 35
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36
Self-citationKim, H., Park, M., Cho, M., Kim, K., Oh, H.-J., Park, J., Heo, Y., Lee, S., Kim, H., & Park, S. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.3.317 · Cited by 34
Macrophage migration inhibitory factor and its role in autoimmune diseases.
Denkinger, C. M., Metz, C. N., Fingerle‐Rowson, G., Denkinger, M. D., & Forsthuber, T. G. (2004) · PubMed · Cited by 34
Targeting chemokine pathways in esophageal adenocarcinoma
Shrivastava, M. S., Hussain, Z., Giricz, O., Shenoy, N. K., Polineni, R. D., Maitra, A., & Verma, A. K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.968426 · Cited by 34
Wettinger, S. B., Doggen, C. J. M., Spek, C. A., Rosendaal, F. R., & Reitsma, P. H. (2004) · Blood · doi:10.1182/blood-2004-08-3283 · Cited by 34
Tumor necrosis factor α stimulates invasion of Src-activated intestinal cells
Kawai, N., Tsuji, S., Tsujii, M., Ito, T., Yasumaru, M., Kakiuchi, Y., Kimura, A., Komori, M., Sasaki, Y., Hayashi, N., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31023 · Cited by 35
Isidori, A. M., Kaltsas, G., Korbonits, M., Pyle, M., Gueorguiev, M., Meinhardt, A., Metz, C. N., Petrovsky, N., POPOVIC, V. M., Bucala, R., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8382 · Cited by 34
A role for NRAGE in NF-κB activation through the non-canonical BMP pathway
Matluk, N. N., Rochira, J. A., Karaczyn, A. A., Adams, T. L., & Verdi, J. M. (2010) · BMC Biology · doi:10.1186/1741-7007-8-7 · Cited by 33
Li, Y., Hsieh, L., Tang, R., Liao, S.-K., & Yeh, K. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.001 · Cited by 33
Stavitsky, A. B., & Xianli, J. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00516-6 · Cited by 33
Brain Miffed by Macrophage Migration Inhibitory Factor
Savaskan, N. E., Fingerle‐Rowson, G., Buchfelder, M., & Eyüpoglu, I. Y. (2012) · International Journal of Cell Biology · doi:10.1155/2012/139573 · Cited by 32
Girard, E., Strathdee, C. A., Trueblood, E. S., & Quéva, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.392 · Cited by 32
Gupta, Y., Pasupuleti, V., Du, W., & Welford, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146482 · Cited by 32
Choufani, G., Ghanooni, R., Decaestecker, C., Delbrouck, K., Simon, P., Schüring, M., Zick, Y., Hassid, S., Gabius, H., & Robert Kiss, A. (2001) · The Laryngoscope · doi:10.1097/00005537-200109000-00031 · Cited by 32
Tomita, M., Irwin, K. I., Xie, Z., & Santoro, T. J. (2002) · Phytotherapy Research · doi:10.1002/ptr.834 · Cited by 32
Narlik‐Grassow, M., Blanco‐Aparicio, C., Cecilia, Y., Pérez, M., Muñoz-Galván, S., Cañamero, M., & Carnero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060277 · Cited by 29
Self-citationVicioso, L., Gonzalez, F. J., Alvarez, M., Ribelles, N., Molina, M., Márquez, A., Pérez, L. M. G., Matilla, A., & Alba, E. (2005) · American Journal of Clinical Pathology · doi:10.1309/0864af2u3lgpcf3j · Cited by 31
Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown
Schrader, J., Deuster, O., Rinn, B., Schulz, M., Kautz, A., Dodel, R. C., Meyer, B., Al‐Abed, Y., Balakrishnan, K., Reese, J. P., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-464 · Cited by 31
Inácio, A. R. L., Bucala, R., & Deierborg, T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-75 · Cited by 31
The Hallmarks of Cancer Review
Hanahan, D., & Weinberg, R. A. (2000) · Cited by 31
Wang, S., Cen, X. B., Liang, X., & Tang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12890 · Cited by 31
Salter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 32
MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer?
Zárate, R., Boni, V., Bandrés, E., & García‐Foncillas, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13010840 · Cited by 30
Kimura, H., Sato, Y., Tajima, Y., Suzuki, H., Yukitake, H., Imaeda, T., Kajino, M., Oki, H., Takizawa, M., & TANIDA, S. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.10.011 · Cited by 30
Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor
Xia, W., Xie, C., Jiang, M., & Hou, M. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2361-y · Cited by 29
Das, R., Moss, J. E., Robinson, E., Roberts, S. J., Levy, R., Mizue, Y., Leng, L., McDonald, C., Tigelaar, R. E., Herrick, C. A., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9541-7 · Cited by 29
Du, J., Xie, X., Chen, H., Yang, W., Dong, M., Su, J., Wang, Y., Yu, C., Zhang, S., & Xu, A. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2004.04.001 · Cited by 30
Dickerhof, N., Magon, N. J., Tyndall, J. D. A., Kettle, A. J., & Hampton, M. B. (2014) · Biochemical Journal · doi:10.1042/bj20140612 · Cited by 30
Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer
He, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i34.9916 · Cited by 29
Wislez, M., Philippe, C., Antoine, M., Rabbe, N., Moreau, J., Bellocq, A., Mayaud, C. M., Milleron, B. J., Soler, P., & Cadranel, J. L. (2004) · Inflammation Research · doi:10.1007/s00011-003-1215-3 · Cited by 31
Xia, H. H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh279 · Cited by 29
Monocytes and Macrophages in Cancer: Unsuspected Roles
Gouveia-Fernandes, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_9 · Cited by 28
Illescas, O., Pacheco‐Fernández, T., Laclette, J. P., Rodríguez, T., & Rodríguez‐Sosa, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155121 · Cited by 28
Ahn, R., & Ursini‐Siegel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052608 · Cited by 30
Guo, Y., Hou, J., Luo, Y., & Wang, D. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-28 · Cited by 28
Inácio, A. R. L., Ruscher, K., & Wieloch, T. W. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.015 · Cited by 28
Honda, A., Abe, R., Yoshihisa, Y., Makino, T., Matsunaga, K., Nishihira, J., Shimizu, H., & Shimizu, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp160 · Cited by 28
Ibraghimov, A. R., & Pappo, J. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01261-2 · Cited by 28
Miki, C., Tonouchi, H., Wakuda, R., Hatada, T., Inoue, Y., Minato, E., Kobayashi, M., & Kusunoki, M. (2002) · Cancer · doi:10.1002/cncr.10324 · Cited by 29
Lefranc, F., Chevalier, C., Vinchon, M., Dhellemmes, P., Schüring, M., Kaltner, H., Brotchi, J., Ruchoux, M., Gabius, H., Salmon, I. J., et al. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.1.0145 · Cited by 28
Xylitol induces cell death in lung cancer A549 cells by autophagy
Park, E.-J., Park, M. H., Na, H. S., & Chung, J. (2015) · Biotechnology Letters · doi:10.1007/s10529-014-1757-1 · Cited by 27
Sherma, N. D., Borges, C. R., Trenchevska, O., Jarvis, J. W., Rehder, D. S., Oran, P. E., Nelson, R. W., & Nedelkov, D. (2014) · Proteome Science · doi:10.1186/s12953-014-0052-3 · Cited by 27
Huang, S., Cao, Y., Lu, M., Peng, W., Lin, J., Tang, C., & Tang, L. (2017) · International Journal for Parasitology · doi:10.1016/j.ijpara.2017.01.005 · Cited by 29
Pham, T.-N. D., Ma, W., Miller, D., Kazakova, L., & Benchimol, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1274-6 · Cited by 27
MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma
Nagarajan, P., Tober, K. L., Riggenbach, J. A., Kusewitt, D. F., Lehman, A. M., Sielecki, T. M., Pruitt, J. R., Satoskar, A. R., & Oberyszyn, T. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0255-t · Cited by 27
Xia, H. H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i13.1946 · Cited by 27
Beielstein, A. C., & Pallasch, C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174158 · Cited by 26
Garofalo, M., Payros, D., Oswald, É., Nougayrède, J., & Oswald, I. P. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153280 · Cited by 33
Meyer‐Siegler, K. L. (2001) · Molecular Medicine · doi:10.1007/bf03401977 · Cited by 27
Brocks, T., Fedorchenko, O., Schliermann, N., Stein, A., Moll, U. M., Seegobin, S., Dewor, M., Hallek, M. J., Marquardt, Y., Fietkau, K., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600860r · Cited by 25
Wang, S., Zheng, M. H., Pang, X., Zhang, M., Yu, X., Wu, J., Gao, X., Wu, J., Yang, X., Tang, Y., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23067 · Cited by 25
Buteyn, N. J., Santhanam, R., Merchand‐Reyes, G., Murugesan, R. A., Dettorre, G. M., Byrd, J. C., Sarkar, A., Vasu, S., Mundy-Bosse, B. L., Butchar, J. P., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900885 · Cited by 25
Relation between colitis and colon cancer
Shanahan, F. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03630-8 · Cited by 25
Review article: colitis‐associated cancer – time for new strategies
Shanahan, F. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.5.x · Cited by 25
Neo, J. C. H., Rose, P. E., Ong, C. N., & Chung, M. C. M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401070 · Cited by 25
Squamous Metaplasia on the Breast Implant Capsule
Alikhan, M. B., Nassar, A., & Mansoor, I. (2009) · International Journal of Surgical Pathology · doi:10.1177/1066896908329587 · Cited by 24
Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
Gaissmaier, L., & Christopoulos, P. (2020) · Respiration · doi:10.1159/000510385 · Cited by 24
Hasenburg, A., Eichkorn, D., Vosshagen, F., Obermayr, E., Geroldinger, A., Zeillinger, R., & Bossart, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-08682-y · Cited by 24
Metadata
- Authors
- Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H.
- Affiliations
- aUnit of Cancer Biology, Institute of Child Health, London WC1N 1EH, United Kingdom
- Centro di Riferimento Oncologico (IT)
- Cold Spring Harbor Laboratory (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-11-15
- Volume
- 190
- Issue
- 10
- Pages
- 1375-1382
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2195698
- OpenAlex
- W2110929110
- Cited by
- 649
- References
- 48
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12 · 2021: 18 · 2020: 25 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 27 · 2015: 24 · 2014: 25 · 2013: 25 · 2012: 38
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
- Funders
- University College London
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- p53, macrophage migration inhibitory factor, inflammatory cytokines, tumor suppressor inactivation, inflammation and tumorigenesis, p53 transcriptional activation, apoptosis, cell proliferation, genome stability
- MeSH terms
- Animals, Cell Line, Chronic Disease, Fibroblasts, Inflammation, Macrophage Migration-Inhibitory Factors, Neoplasms, Nitric Oxide, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
